Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects

Circulation

Volumn 96, Issue 10, 1997, Pages 3390-3395

  Hasdai, David ^a   Gibbons, Raymond J ^a   Holmes Jr , David R ^a   Higano, Stuart T ^a   Lerman, Amir ^a  

^a MAYO CLINIC   (United States)

Author keywords

Angina; Coronary disease; Microcirculation; Perfusion; Vasodilation

Indexed keywords

ADULT; AGED; ANGINA PECTORIS; ARTERY DIAMETER; ARTICLE; BLOOD VESSEL TONE; CLINICAL ARTICLE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY OBSTRUCTION; ENDOTHELIUM LESION; EPICARDIUM; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; MALE; MICROCIRCULATION; PRIORITY JOURNAL;

EID: 0030728423     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.10.3390     Document Type: Article

References (40)

1. Lerman A, Burnett JC Jr. Intact and altered endothelium in regulation of vasomotion. Circulation. 1992;86(suppl 3):III-12-III-19.
2. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation. 1995;91:2345-2352.
3. Yeung AC, Vekshtein VI, Krantz DS, Vita JA, Ryan TJ Jr, Ganz P, Selwyn AP. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. N Engl J Med. 1991;325: 1551-1556.
4. Gordon JB, Ganz P, Nabel KG, Fish RD, Zebede J, Mudge GH, Alexander RW, Selwyn AP. Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise. J Clin Invest. 1989;83:1946-1952.
5. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002-2012.
6. Reddy KG, Nair RN, Sheehan HM, Hodgson JM. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 1994;23:833-843.
7. Penny WF, Rockman H, Long J, Bhargava V, Carrigan K, Ibriham A, Shabetai R, Ross J Jr, Peterson KL. Heterogenity of vasomotor response to acetylcholine along the human coronary artery. J Am Coll Cardiol. 1995;25:1046-1055.
8. Di Marco C, Strikwerda S, Gil R, de Feyter PJ, de Jaegere P, Serruys PW. Response of conductance and resistance coronary vessels to scalar-concentrations of acetylcholine: assessment with quantitative angiography and intracoronary Doppler echography in 29 patients with coronary artery disease. Am Heart J. 1994;127: 514-531.
9. el-Tamimi H, Mansour M, Wargovich TJ, Hill JA, Kerensky RA, Conti CR, Pepine CJ. Constrictor and dilator responses to intracoronary acetylcholine in adjacent segments of the same coronary artery in patients with coronary artery disease: endothelial function revisited. Circulation. 1994;89:45-51.
10. Dubois-Rande JL, Dupouy P, Geschwind H, Castaigne A, Adnot S. Intracoronary linsidomine abolishes acetylcholine-induced vasoconstriction of epicardial coronary arteries. J Cardiovasc Pharmacol. 1993;22:462-467.
11. Sekiya M, Okayama H, Suzuki M, Kobayashi T, Matsuoka H, Sumimoto T, Hamada M, Hiwada K. Acetylcholine-induced myocardial ischemia without epicardial coronary artery spasm: a possible vasospasm of small coronary arteries - a case report. Angiology. 1993;44:811-815.
12. Egashira K, Inou T, Hirooka Y, Yamada A, Urabe Y, Takeshita A. Evidence of impaired endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary angiograms. N Engl J Med. 1993;328:1659-1664.
13. Egashira K, Inou T, Hirooka Y, Yamada A, Maruoka Y, Kai H, Sugimachi M, Suzuki S, Takeshita A. Impaired coronary blood flow response to acetylcholine in patients with coronary risk factors and proximal atherosclerotic lesions. J Clin Invest. 1993;91:29-37.
14. Zeiher AM, Drexler H, Wollschlager H, Just H. Modulation of coronary vasomotor tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation. 1991;83:391-401.
15. Quyyumi AA, Cannon RO III, Panza JA, Diodati JG, Epstein SE. Endothelial dysfunction in patients with chest pain and normal coronary arteries. Circulation. 1992;86:1864-1871.
16. Gibbons RJ. Technetium 99m sestamibi in the assessment of acute myocardial infarction. Semin Nucl Med. 1991;21:213-222.
17. Beller GA, Watson DD. Physiological basis of myocardial perfusion imaging with the technetium 99m agents. Semin Nucl Med. 1991; 21:173-181.
18. Schofield PM, Whorwell PJ. Angina-like chest pain: head, heart or oesophagus? Br J Hosp Med. 1990;43:443-447.
19. Crow RS, Prineas RJ, Jacobs DR Jr, Blackburn H. A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changes. Am J Cardiol. 1989;64: 454-461.
20. Braunwald E. Unstable angina: a classification. Circulation. 1989; 80:410-414.
21. Lerman A, Holmes DR Jr, Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr. Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation. 1995;92:2426-2431.
22. Hasdai D, Cannan CR, Mathew V, Holmes DR Jr, Lerman A. Evaluation of patients with minimally obstructive coronary artery disease and angina. Int J Cardiol. 1996;53:203-208.
23. Hori M, Kitakaze M. Adenosine, the heart and coronary circulation. Hypertension. 1991;18:565-574.
24. Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993;87:1461-1467.
25. Bove AA, Holmes DR Jr, Owen RM, Bresnahan JF, Reeder GS, Smith HC, Vlietstra RE. Estimation of the effects of angioplasty on coronary stenosis using quantitative video angiography. Cathet Cardiovasc Diagn. 1985;11:5-16.
26. Ofili EO, Labovitz AJ, Kern MJ. Coronary flow velocity dynamics in normal and diseased arteries. Am J Cardiol. 1993;71:3D-9D.
27. Pinto FJ, St. Goar FG, Fischell TA, Stadius ML, Valantine HA, Alderman EL, Popp RL. Nitroglycerin-induced coronary vasodilation in cardiac transplant recipients: evaluation with in vivo coronary ultrasound. Circulation. 1992;85:69-77.
28. Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ. Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol. 1995;26:41-49.
29. Nishimura RA, Edwards WD, Warnes CA, Reeder GS, Holmes DR Jr, Tajik AJ, Yock PG. Intravascular ultrasound imaging: in vitro validation and pathological correlation. J Am Coll Cardiol. 1990;16:145-154.
30. St. Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stadius ML, Popp RL. Intravascular ultrasound imaging of angiographically normal coronary arteries: an in vivo comparison with quantitative angiography. J Am Coll Cardiol. 1991;18:952-958.
31. 99mTc-hexakis-2 methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction. Circulation. 1989;80: 1277-1286.
32. 99mTc sestamibi imaging predicts subsequent mortality. Circulation. 1995;92:334-341.
33. Gould KL, Ornish D, Scherwitz L, Brown S, Edens RP, Hess MJ, Mullani N, Bolomey L, Dobbs F, Armstrong WT, Merritt T, Ports T, Sparler S, Billings J. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274:894-901.
34. Jones CJ, Kuo L, Davis MJ, DeFily DV, Chilian WM. Role of nitric oxide in the coronary microvascular responses to adenosine and increased metabolic demand. Circulation. 1995;91:1807-1813.
35. Treasure CB, Vita JA, Cox DA, Fish RD, Selwyn AP, Alexander RW, Ganz P. Acute myocardial infarction with normal coronary arteries associated with acetylcholine-induced vasoconstriction in the absence of a positive ergonovine test. Am J Cardiol. 1990;65: 255-257.
36. Uzui H, Kondo M, Murayama T, Nishiue T, Tsubokawa A, Tanio H, Shimono Y. Assessment of left ventricular myocardial perfusion and diastolic function during acetylcholine-induced diffuse coronary vasoconstriction by Doppler echocardiography and thallium-201 scintigraphy. Coron Artery Dis. 1995;6:489-496.
37. Euchner-Wamser I, Meller ST, Gebhart GF. A model of cardiac nociception in chronically mediated rats: behavioral and electrophysiological effects of pericardial administration effects of pericardial administration of algogenic substances. Pain. 1994;58: 117-128.
38. Zhuo M, Meller ST, Gebhart GF. Endogenous nitric oxide is required for tonic cholinergic inhibition of spinal mechanical transmission. Pain. 1993;54:71-78.
39. Rigel DF, Lappe RW. Differential responsiveness of conduit and resistance coronary arteries to endothelin A and B receptor stimulation in anesthetized dogs. J Cardiovasc Pharmacol. 1993; 22(suppl 8):S243-S247.
40. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of coronary endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet. 1991;338:1546-1550.